Table 1.
δΔCt (95%CI) |
|||||
---|---|---|---|---|---|
TERT rs401681 | Breast Cancer 6434 controls |
Melanoma 979 controls |
SIBS 1655 controls |
Colorectal Cancer 2246 controls |
Combined 11314 controls |
CC | 0.00 ref | 0.00 ref | 0.00 ref | 0.00 ref | 0.00 ref |
CT | −0.002 (−0.02 - 0.02) | 0.06 (0.003 - 0.1) | −0.002 (−0.04 - 0.04) | 0.01 (−0.02 - 0.05) | 0.02 (−0.005 - 0.04) |
TT | −0.02 (−0.03 - 0.02) | 0.03 (−0.05 - 0.1) | 0.03 (−0.02 - 0.08) | 0.004 (−0.04 - 0.05) | 0.04 (−0.03 - 0.04) |
Per T allele | p-trend=0.86 | p-trend=0.38 | p-trend=0.29 | p-trend=0.78 | p-trend=0.61 |
Genotype frequencies and mean telomere length, as represented by the continuous ΔCt variable, were analysed in control samples using linear regression, for the ‘per T allele’ change in mean telomere length (δΔCt), with associated 95% confidence intervals (95% CI). Analyses were adjusted for 384-well plate and age in all the studies and for gender and family where applicable.